Author： Press Michael F.
Publisher： Adis International
ISSN： 0012-6667
Source： Drugs, Vol.67, Iss.14, 2007-01, pp. : 2045-2075
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
VEGF Signaling in Cancer Treatment
Current Pharmaceutical Design, Vol. 20, Iss. 17, 2014-05 ,pp. :
Access to resources
Recommend
Insight into the Medicinal Chemistry of EGFR and HER-2 Inhibitors
Current Medicinal Chemistry, Vol. 21, Iss. 11, 2014-04 ,pp. :
HER2-Positive Breast Cancer: Current and Future Treatment Strategies
By Engel Ryan H. Kaklamani Virginia G.
Drugs, Vol. 67, Iss. 9, 2007-01 ,pp. :
Pertuzumab: In the First-Line Treatment of HER2-Positive Metastatic Breast Cancer
Drugs, Vol. 72, Iss. 3, 2012-02 ,pp. :